Neudle.com: multiple sclerosis isolated syndrome

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

addiction, heroin

addiction, heroin-neurologic complications with

adverse drug reaction

akinetic mute

algorithm

alternating rapid movement

amyloid angiopathy, cerebral

amyloid angiopathy, cerebral, inflammatory type

amyloid beta protein

amyloid beta-related angiitis

aneurysm

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

angiitis, isolated of CNS, benign focal

angiography, cerebral, beaded vessels

angiography, cerebral

angiography, cerebral, false negative

angiography, cerebral, reversible abnormality

antibodies to myelin basic protein

antimyelin antibodies

autoimmune cerebellar ataxia

Barkhof MR criteria for MS

basal ganglia, infarction

basal ganglia, lesion of

brain biopsy, false negative

brain volume

brainstem

brainstem, atrophy

brainstem, infarction of

brainstem, lesion of

bulbar palsy

calcium antagonist

Call-Fleming syndrome

carbamazepine

carbon monoxide poisoning

CAT scan, contrast enhanced, delayed

CAT scan, contrast enhanced, double dose

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

CAT scan, serial

central nervous system, infection of

central pontine myelinolysis

central vein sign

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellum

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral edema

cerebral edema, vasogenic

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral infarction, subcortical

cerebral peduncle

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, culture of, viral

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrospinal fluid, red cells in

cerebrovascular accident

cerebrovascular accident, bilateral

cerebrovascular accident, familial occurrence

cerebrovascular accident, multiple

cerebrovascular accident, recurrent

cerebrovascular accident, women

cervical spine

chasing the dragon

chemotherapy, CNS treatment and complications with

children

chin numbness

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

cognition

collagen vascular disease

confusional state, acute

controversies in neurology

cop 1

corpus callosum

corpus callosum, lesion of

degenerative diseases of CNS

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dental procedure, neurologic complications with

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

dizziness

drug abuse

drug abuse, inhalation

drug abuse, neurologic complications of

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

endocarditis

epidemiology of neurology

Epstein-Barr virus

Erdheim-Chester disease

ethics in neurology

evoked potentials

extinction on double simultaneous stimulation

eye movement, disorders of

face, numbness of

facial weakness

facial weakness, bilateral

falling

familial

food-borne infection

fourth ventricle, shift of

gadolinium

gait disorder

gammaglobulin therapy, intravenous

gastroenteritis

gaze palsy

gaze palsy, horizontal

gender

gene mutation

genetic neurologic disorders

gliomatosis cerebri

glutamic acid decarboxylase, antibody

granular osmiphilic material

granulomatous disease

headache, sudden onset of

headache, thunderclap

hearing loss

hearing loss, sudden, unilateral

heel-knee-shin test

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hemiplegia, progressive

hepatolenticular degeneration(Wilson's disease)

heralding manifestation

herpes simplex virus

herpes virus

herpes zoster

herpes zoster, ophthalmicus

hiccoughs

histiocytosis

human immunodeficiency virus type 1

human immunodeficiency virus type 1, asymptomatic

hydrocephalus

hydrocephalus, exvacuo

hyperreflexia

hypersomnia

hypertensive encephalopathy

iatrogenic neurologic disorders

immunomodulation

immunosuppressive agents

incoordination

intellectual deficit

intellectual deterioration

internuclear ophthalmoplegia

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intravenous

iron, brain

Jakob-Creutzfeldt disease

Kappa light chain biomarkers

Kayser-Fleischer ring

laughing, pathologic

leukoencephalopathy

leukoencephalopathy, differential diagnosis

leukoencephalopathy, toxic

level of consciousness, decreased

limbic encephalitis

listeria monocytogenes

lymphoma involving CNS

lymphoma, primary of CNS

MAGNIMS group

McDonald criteria for MS

medulla oblongata, lesion of

memory, impairment of

meningeal biopsy

meningeal enhancement

meningismus

meningitis, aseptic

mental nerve

mental nerve neuropathy

mental status, abnormal

mitochondrial disease

MRI, angiography, false negative

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, gradient-echo

MRI, incidental finding

MRI, lesion burden

MRI, negative

MRI, optic nerve

MRI, paramagnetic effect

MRI, protocol

MRI, ring sign, open

MRI, serial

MRI, snowball lesions

MRI, spinal cord

MRI, susceptibility weighted

MRI, volumetry

MRS

multiple sclerosis

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, clinically isolated syndrome

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pain in

multiple sclerosis, paroxysmal symptoms in

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, tumefactive

N-acetyl-L-aspartic acid

nausea and vomiting

neoplasm, metastatic

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic symptoms

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuroophthalmology

neuropathology

neuroprotective agents

Notch3 gene

numb chin syndrome

nystagmus

nystagmus, primary position of gaze

ocular bobbing

optic nerve, lesion of

optic neuritis

optic neuritis, etiology of

optic neuritis, treatment of

optical coherence tomography

optokinetic nystagmus(O.K.N.)

optokinetic nystagmus, abnormal

osteoblastic lesions, causes of

pain

pain, back

paramagnetic rim lesion, MR

paraneoplastic cerebellar degeneration

Parkinsonism syndrome

paroxysmal neurologic deficits

PAS positive

PAS positive material in the brain

periventricular leukomalacia

personality change

phenylketonuria

pleocytosis of cerebrospinal fluid

pons, infarction of

pons, lesion of

posterior fossa

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudobulbar palsy

psychiatric problems in neurologic disorders

pursuit eye movements, abnormal

pyramidal tract

pyramidal tract dysfunction

quadriparesis

quadriplegia

race

radiation therapy, CNS treatment and complications with

Rankin score

rapidly progressing neurologic illness

Red flags

rehabilitation for neurologic disorders

remote effect of cancer on the nervous system

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis factor(R.A.factor)

rigidity

risk factors

saccadic eye movements, abnormal

scotoma, paracentral-homonymous

sedimentation rate, elevated

seizure

seminoma

sensorineural hearing loss

serologic testing

sickle cell disease

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spinal cord, cervical

spinal cord, ischemic lesion of

spinal cord, lesion of

standing difficulty

steroid

steroid therapy, CNS treatment and complications with

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

Susac's syndrome

symmetric brain lesions

symptomatic

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tandem gait, ataxic

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thyroiditis

tinnitus

tongue, impaired movements of

tonic spasms

toxic encephalopathy

treatment of neurologic disorder

tremor

trigeminal neuralgia

trigeminal neuropathy

trigeminal neuropathy, sensory

tumefactive lesion

vasculitides

vasculopathy

vasoconstrictive drugs

vasospasm, cerebral

ventricular enlargement

visual evoked response

visual field defect

visual loss

visual symptoms

walking, difficulty with

water channel antibodies

white matter disease, periventricular

work loss

workup

Showing articles 300 to 350 of 4647 << Previous Next >>

Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014

The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014

An Unusual Headache
BMJ 349:g5602, Graham, U.M.,et al, 2014

Safety and Efficacy of Ofatumumab in Relapsing-Remitting Multiple Sclerosis
Neurol 82:573-581, Sorensen, P.S.,et al, 2014

Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis
NEJM 370:792-794, McMinn, P.C., 2014

Relapsing-Remitting Tumefactive Demyelination
JAMA Neurol 71:366-367, Brandao, E.,et al, 2014

Daclizumab-Induced Adverse Events in Multiple Organ Systems in Multiple Sclerosis
Neurol 82:984-988, Oh, J.,et al, 2014

Summary of Evidence-Based Guideline: Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:1083-1092, Yadav, V.,et al, 2014

Complementary and Alternative Medicine in Multiple Sclerosis
Neurol 82:e103-e104, Fox, R.J., 2014

Effect of high-dose Simvastatin on Brain Atrophy and Disability in Secondary Progressive Multiple Sclerosis (MS-STAT): A Randomised, Placebo-Controlled, Phase 2 Trial
Lancet 383:2213-2221, Chataway, J.,et al, 2014

Recommendations for the Management of Cerebral and Cerebellar Infarction with Swelling
Stroke 45:1222-1238, Wijdicks, E.F.M.,et al, 2014

Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke
NEJM 370:1091-1100,1159, Juttler, E.,et al, 2014

ICU-Acquired Weakness and Recovery from Critical Illness
NEJM 370:1626-1635, Kress, J.P. & Hall, J.B., 2014

Superficial Abdominal Reflex
NEJM 370:e29, Baden, L.R., 2014

Should Doctors Prescribe Cannabinoids?
BMJ 348:g2737, Farrell, M.,et al, 2014

Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014

Intensive Care Unit Admission in Multiple Sclerosis
Neurol 82:2112-2119, Marrie, R.A.,et al, 2014

Balos Concentric Sclerosis
Lancet Neurol 13:740-746, Hardy, T.A. & Miller, D.H., 2014

Degenerative Diseases of the Nervous System, Progressive Bulbar Palsy
Adams & Victors Principles of Neurology, Chp 39, pg 1111, Ropper, A.H.,et al, 2014

Addition of Hyperacute MRI Aids in Patient Selection, Decreasing the Use of Endovascular Stroke Therapy
Stroke 45:467-472, Wisco, D.,et al, 2014

Mycophenolate Mofetil in Multiple Sclerosis: A Multicentre Retrospective Study on 344 Patients
JNNP 85:279-283,246, Michel, L.,et al, 2014

Herpes Simplex Virus Encephalitis:Clinical Manifestations,Diagnosis and Outcome in 106 Adult Patients
J Clin Virol 60:112-118, Sili,U.,et al, 2014

Paraneoplastic Neurological Syndromes
Clin Exp Immunol 175:336-348, Leypoldt, F. & Wandinger, K.-P., 2014

Central Nervous System Lymphoma Initial Diagnosed as Tumefective Multiple Sclerosis after Brian Biopsy
Intern Med 52:483-488, Ohe, Y.,et al, 2013

Anti-Aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Balos Concentric Lesions
Intern Med 52:1517-1521, Masuda, H.,et al, 2013

Clinical Features of MS Associated with Leber Hereditary Optic Neuropathy mtDNA Mutations
Neurol 81:2073-2081, Pfeffer, G.,et al, 2013

Longitudinally Extensive Transverse Myelitis with and Without Aquaporin 4 Antibodies
JAMA Neurol 70:1375-1381, Kitley, J.,et al, 2013

An Expanded Role for Neuroimaging in the Evaluation of Memory Impairment
AJNR 34:2075-2082, Desikan, R.S.,et al, 2013

Extensive Vasogenic Edema of Anti-Aquaporin-4 Antibody-Related Brain Lesions
Mult Scler 15:1113-1117, Matsushita, T.,et al, 2013

Subacute Sclerosing Panencephalitis
www.MedLink.com, February, Auwaeter,P.G.&Johnson,R.T., 2013

Three Times Weekly Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
Ann Neurol 73:705-713, Khan, O.,et al, 2013

Interdependence and Contributions of Sun Exposure and Vitamin D to MRI Measures in Multiple Sclerosis
JNNP 84:1075-1081, 1066, Zivadinov, R.,et al, 2013

Tumefactive MS Lesions under Fingolimod
Neurol 81:1654-1658, Pilz, G.,et al, 2013

Functional Impairment in Progressive Supranuclear Palsy
Neurol 80:380-384, Duff, K.,et al, 2013

Varicella-Zoster Virus Acute Myelitis in a Patient with MS Treated with Natalizumab
Neurol 80:1812-1813, Yeung, J.,et al, 2013

Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013

Interferon beta for Secondary Progressive Multiple Sclerosis: A Systematic Review
JNNP 84:420-426, La Mantia, L.,et al, 2013

Disability in Multiple Sclerosis
Neurol 80:1018-1024, Kister, I.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:190-194, Gold, R.,et al, 2013

Clinical Spectrum of CNS Aquaporin-4 Autoimmunity
Neurol 78:1179-1185, Kim, S.,et al, 2013

Differential Diagnosis of Neuromyelitis Optica Spectrum Disorders
Brain Neurol 62:953-960, Tanaka, T., 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200, 2176, Marignier, R.,et al, 2013

Characterising Aggressive Multiple Sclerosis
JNNP doi:10.1136 1-7, Menon, S.,et al, 2013

Aquaporin-4 Antibody-Negative Neuromyelitis Optica
Neurol 80:2194-2200,2176, Maringer, R.,et al, 2013

Aquaporin-4 Antibody-Positive Cases Beyond Current Diagnosis Criteria for NMO Spectrum Disorders
Neurol 80:2210-2216, Sato, D.,et al, 2013

Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 381:2167-2175, Gold, R.,et al, 2013

Clinicopathologic Conference, Blind and Confused, Neuromyelitis Optica Spectrum Disorder
JAMA Neurol 70:932-936, Sharma, V.,et al, 2013

The Thalamus and Multiple Sclerosis
Neurol 80:210-219, Minagar, A.,et al, 2013

Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Ann Neurol 74:679-687, Krueger, D.A.,et al, 2013

Cerebral Venous Thrombosis after High Dose Steroid in Multiple Sclerosis: A Case Report
Hippokratia 17:88-90, Gazioglu, S.,et al, 2013

Showing articles 300 to 350 of 4647 << Previous Next >>